# SUMMARY OF SAFETY AND EFFECTIVENESS

IDENTIFICATION INFORMATION

SUBMITTERS INFORMATION

This summary of 510(k) safety and effectiveness is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.20.

SUBMITTER'S NAME AND ADDRESS: Meridian BioscienCe, Inc. 3471 River Hills Drive Cincinnati, OH 45244

PHONE NUMBER: (513) 271-3700

FAX NUMBER: (513) 272-5213

CONTACT PERSON: SuSaN Rolih Official correspondent

DATE SUMMARY PREPARED: AugUSt 29, 2006

TRADE NAME: ImmUnOCard STAT! EHEC

COMMON NAME: E coli toxins detection test

CLASSIFICATION NAME: Escherichia coli serological reagents

REGULATION: 866.3255

INTENDED USES: ImmunoCard STAT! EHEC is an immunochromatographic rapid test for the qualitative detection of Shiga toxins 1 and 2 (also called Verotoxins) produced by E. coli in cultures derived from clinical stool specimens. ImmunoCard STAT! EHEC is used in conjunction with the patient's clinical symptoms and other laboratory tests to aid in the diagnosis of diseases caused by enterohemorrhagic E. coli (EHEC) infections.

PREDICATE DEVICE: Premier EHEC (K953362)

BACKGRouND: Among the E. coli human pathogens, Shiga toxin—producing strains of E. coli have gained in importance in recent years. The group of EHEC, with their highly pathogenic serovars O157:H7, 026, 0103, 0111, 0145, and other strains are of particular concern. Production of Shiga toxins is the most common criteria for the detection of this group of bacteria. Shiga toxins can be classified into two main categories: Shiga toxin 1 (ST1) and Shiga toxin 2 (ST2). EHEC strains may produce ST1 or ST2 only or both ST1 and ST2 simultaneously. EHEC are capable of initiating life-threatening illnesses, particularly in young children, the eldery or patients with immune deficiency. The main sources of infection are contaminated, raw or insufficiently heated foods of animal origin, eg, meat and dairy products. The reservoir for EHEC is the feces of cattle, sheep and goats. These microorganisms can enter food during the processing of meat and dairy products if hygienic conditions are inadequate. The incidence of food infection caused by Shiga toxin-producing E. coli demands reliable and rapid methods of detection. In addition to traditional culture methods, immunological techniques are becoming more useful due to their improved specificity and sensitivity. ImmunoCard STAT! EHEC is an immunological screening test based on the lateral flow principle.

This product was previously cleared to market as Duopath Verotoxin GLISA (K031367) to identify Shiga toxin 1 or Shiga toxin 2-producing strains of E coli isolated from colonies derived from human stoois cultured on Sorbitol MacConkey agar plates. This application adds a new intended use to the device (use with broth cultures inoculated with human stool) and changes the name of the product.

# Type of test

Qualitative, rapid, single use, immunochromatographic assay

# Specimen type

Human stool samples inoculated into enrichment media (GN or Mac broth) (This application.)

# Conditions for use

ImmunoCard STAT! EHEC is designed for use by laboratory professionals under normal environmental conditions. The assay, which is stored at 2-8 C when not in use, is brought to rotemperature (0-5 )beforesNormal laboratory lighting,humidiy and temperatuo not affect the performance f the assay.

# Contraindications

There are no contraindications associated with the use of this product.

Special instrument requirements No instruments are used with this device.

Combination with other medical devices No other medical devices are used in combination with this device.

<table><tr><td rowspan=2 colspan=1>Characteristics</td><td rowspan=2 colspan=1>ImmunoCard STAT! EHEC</td><td rowspan=2 colspan=1>Premier EHEC(predicate)</td><td rowspan=2 colspan=1>Duopath Verotoxin GLISA(predicate)</td></tr><tr><td rowspan=20 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Device Type</td><td rowspan=1 colspan=1>ROBIEOS</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>EaNctentaerea52CA</td></tr><tr><td rowspan=1 colspan=1>Technology</td><td rowspan=1 colspan=1>Single use, rapid, lateral flowimmunoassay</td><td rowspan=1 colspan=1>Microwell-based enzyme-linkedimmunoassay</td><td rowspan=1 colspan=1>Single use, rapid, lateral flowimmunoassay</td></tr><tr><td rowspan=1 colspan=1>In vitro diagnostic device</td><td rowspan=1 colspan=1>Yes</td><td rowspan=1 colspan=1>Yes</td><td rowspan=1 colspan=1>Yes</td></tr><tr><td rowspan=1 colspan=1>Control</td><td rowspan=1 colspan=1>Includes external control reagent</td><td rowspan=1 colspan=1>Includes external control reagent</td><td rowspan=1 colspan=1>No control reagent included</td></tr><tr><td rowspan=1 colspan=1>Calibrator</td><td rowspan=1 colspan=1>No</td><td rowspan=1 colspan=1>No</td><td rowspan=1 colspan=1>No</td></tr><tr><td rowspan=1 colspan=1>Assay Features</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>E</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Human factors</td><td rowspan=1 colspan=1>No special equipment</td><td rowspan=1 colspan=1>ElA-related equipment</td><td rowspan=1 colspan=1>No special equipment</td></tr><tr><td rowspan=1 colspan=1>Sterile device</td><td rowspan=1 colspan=1>No</td><td rowspan=1 colspan=1>No</td><td rowspan=1 colspan=1>No</td></tr><tr><td rowspan=1 colspan=1>Mechanical safety</td><td rowspan=1 colspan=1>Not applicable</td><td rowspan=1 colspan=1>Not applicable</td><td rowspan=1 colspan=1>Not applicable</td></tr><tr><td rowspan=1 colspan=1>Environmental safety</td><td rowspan=1 colspan=1>Normal medical waste</td><td rowspan=1 colspan=1>Normal medical waste</td><td rowspan=1 colspan=1>Normal medical waste</td></tr><tr><td rowspan=1 colspan=1>Chemical hazards</td><td rowspan=1 colspan=1>None</td><td rowspan=1 colspan=1>None</td><td rowspan=1 colspan=1>None</td></tr><tr><td rowspan=1 colspan=1>Radiation safety</td><td rowspan=1 colspan=1>Not applicable</td><td rowspan=1 colspan=1>Not applicable</td><td rowspan=1 colspan=1>Not applicable</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>TasN0600s</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Aoe</td></tr><tr><td rowspan=1 colspan=1>Detection of Shiga toxinsand 2</td><td rowspan=1 colspan=1>Yes</td><td rowspan=1 colspan=1>Yes</td><td rowspan=1 colspan=1>Yes</td></tr><tr><td rowspan=1 colspan=1>Differentiation      betweenShiga toxins 1 and 2</td><td rowspan=1 colspan=1>Yes</td><td rowspan=1 colspan=1>No</td><td rowspan=1 colspan=1>Yes</td></tr><tr><td rowspan=1 colspan=1>Screening test</td><td rowspan=1 colspan=1>Yes</td><td rowspan=1 colspan=1>Yes</td><td rowspan=1 colspan=1>Yes</td></tr><tr><td rowspan=1 colspan=1>Diagnostic test</td><td rowspan=1 colspan=1>No</td><td rowspan=1 colspan=1>No</td><td rowspan=1 colspan=1>No</td></tr><tr><td rowspan=1 colspan=1>Identification test</td><td rowspan=1 colspan=1>Yes</td><td rowspan=1 colspan=1>No</td><td rowspan=1 colspan=1>Yes</td></tr><tr><td rowspan=1 colspan=1>Monitoring therapy</td><td rowspan=1 colspan=1>No</td><td rowspan=1 colspan=1>No</td><td rowspan=1 colspan=1>No</td></tr></table>

<table><tr><td rowspan=2 colspan=1>Do o GoonA</td><td rowspan=2 colspan=1>N</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>N</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>Ce o  b </td><td rowspan=2 colspan=1>i ce</td><td rowspan=2 colspan=1>P8</td><td rowspan=2 colspan=1>N</td><td rowspan=2 colspan=1>N</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>S</td><td rowspan=2 colspan=1>N</td><td rowspan=2 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=2 colspan=1>Nuon</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>NuoN</td><td rowspan=2 colspan=1>Wod keeaar</td><td rowspan=2 colspan=1>5</td><td rowspan=2 colspan=1>pina paa-aud</td><td rowspan=2 colspan=1>Jooo o = bo pue Jooo = od</td></tr><tr><td rowspan=1 colspan=1>Wwuooou munr</td><td rowspan=1 colspan=1>Wwuoouoc munc</td><td rowspan=1 colspan=1>Wuoooc muncl</td><td rowspan=1 colspan=1>Wwuooou mun</td></tr><tr><td rowspan=1 colspan=1>Per eeaC(ejecped</td><td rowspan=1 colspan=1>S</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Woc po-oq</td><td rowspan=1 colspan=1>seee aae pue</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>S</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>Se</td><td rowspan=1 colspan=1>A</td><td rowspan=1 colspan=1>NWuuoouou mun</td><td rowspan=1 colspan=1>Wuaooc mune</td><td rowspan=1 colspan=1>Rra gqd</td><td rowspan=1 colspan=1>Reuakk gad</td><td rowspan=1 colspan=1>la pen</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>eareleae</td><td rowspan=1 colspan=1>Wodo keeaar</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>Jaoo CO</td><td rowspan=1 colspan=1>(0ee (n 0a0 &lt;00</td></tr><tr><td rowspan=2 colspan=1>Mn  poC</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>N</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>se  a sodus</td><td rowspan=2 colspan=1>ioe e</td><td rowspan=2 colspan=1>10</td><td rowspan=2 colspan=1>N</td><td rowspan=2 colspan=1>N</td><td rowspan=2 colspan=1>0</td><td rowspan=2 colspan=1>S0</td><td rowspan=2 colspan=1>e</td><td rowspan=2 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=2 colspan=1>lt pejan</td><td rowspan=2 colspan=1>3 </td><td rowspan=2 colspan=1>Nuon</td><td rowspan=2 colspan=1>Wodcrn eeaar</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>pia pe-aand</td><td rowspan=2 colspan=1>Jooo co = bo pd Jaoo = sod</td></tr><tr><td rowspan=1 colspan=1>Wwuooou mnr</td><td rowspan=1 colspan=1>Wwuooon mnn</td><td rowspan=1 colspan=1>Wuooou ne</td><td rowspan=1 colspan=1>Wwuooou munc</td></tr><tr><td rowspan=1 colspan=1>Aeccce aeeae</td><td rowspan=1 colspan=1>So bo coe</td><td rowspan=1 colspan=1>soo ebe caane</td><td rowspan=1 colspan=1>Crre el</td><td rowspan=1 colspan=1>seeuodc/uenspopad</td><td rowspan=1 colspan=1>tspe iem</td><td rowspan=1 colspan=1>ueeed een</td><td rowspan=1 colspan=1>Giteneunoue connSdmee</td><td rowspan=1 colspan=1>See reas</td><td rowspan=1 colspan=1>sonon Sos</td><td rowspan=1 colspan=1>c cn ee coe</td><td rowspan=1 colspan=1>ch cn n ea</td><td rowspan=1 colspan=1>r e </td><td rowspan=1 colspan=1>oaiiq/iieSocee</td><td rowspan=1 colspan=1>cepoqe  ses</td><td rowspan=1 colspan=1>sepqe  ses</td><td rowspan=1 colspan=1>sepoo se aoe</td><td rowspan=1 colspan=1>seeoe J</td><td rowspan=1 colspan=1>Co r</td><td rowspan=1 colspan=1>son Sesse o osdes</td><td rowspan=1 colspan=1>pennbd ned</td><td rowspan=1 colspan=1>pen  o </td><td rowspan=1 colspan=1>asss Sesse</td><td rowspan=1 colspan=1>Buod pi</td><td rowspan=1 colspan=1>resuintejedejBuod pi</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Performance Characteristics</td><td rowspan=1 colspan=1>ImmunoCard STAT! EHEC</td><td rowspan=1 colspan=1>Premier EHEC(predicate)</td><td rowspan=1 colspan=1>Duopath Verotoxin GLISA</td></tr><tr><td rowspan=1 colspan=1>Clinical Sensitivity</td><td rowspan=1 colspan=1>90.3%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>Not calculated</td></tr><tr><td rowspan=1 colspan=1>Clinical Specificity</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>97.9%</td><td rowspan=1 colspan=1>Not calculated</td></tr><tr><td rowspan=1 colspan=1>Precision/Reproducibility(intra-assay)</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Linearity/reportable range</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>Analytical        limit        ofdetection/sensitivity</td><td rowspan=1 colspan=1>ST1 = 25 ug/mLST2 = 25 ug/mL</td><td rowspan=1 colspan=1>ST1 = 7 pg/wellST2 = 15 pg/well</td><td rowspan=1 colspan=1>ST1 and ST2 = one colony perenrichment broth</td></tr><tr><td rowspan=1 colspan=1>Assay cutoff</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>OD 0.150 (dual wavelength)</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>Indeterminant range</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td></tr></table>

# DEVICE DESCRIPTION AND TECHNOLOGICAL PRINCIPLES

# Construct

Each ImmunoCard STAT! EHEC test kit contains three reagents/components.

1. Test Devices, in individual foil pouches with desiccants. 2. Sample Diluent (Negative Control) in a plastic dropper vial Positive Control in a plastic dropper vial

# Calibrators

No calibrators are needed for this device.

# Controls

This assay includes an internal control line that is used to demonstrate hat the broth samples have been applid, that it has flowed correctly, and that the conjugated detector antibodies are active at the timeo use. A colorless to faint pink background around the Toxin 1 and 2 Test Lines serves as a negative control and indicates the reagents were performing correctly at the time of testing.

The Positive Control exteral control reagent isused with the Sample Diluent/Negative Control when extemal conol testig is warrantd.The reagents also serve as indicators that the test was peroed coey ha reagents were active and specific at the time of use, and that the Test Device membrane supports proper sample flow.

Failu hentalanexeacnts  ouhpecesugsthestwaso pe correctly.

# Technological principles

ImmunoCard STAT! EHEC is an immunochromatographic rapid test utilizing monoclonal antibodies labeled with red-colored gold particles.The test device has a circular sample port and an oval-shaped test (Toxin 1, Toxin 2) and control (Control) window.

1.The sample is applied to the chromatography paper via the circular sample port (Sample).   
2.The sample is absorbed through the pad to the reaction zone containing colloidal, gold-labeled antibodies specific to Shiga toxins.   
3.Any Shiga toxin (ST1 and ST2) antigen present complexes with the gold-labeled antibody and migrates through the pad until it encounters the binding zones in the test (Toxin 1, Toxin 2) area.   
4.The binding zones (Toxin 1 and Toxin 2) contain another anti-ST1 or -ST2 antibody, which immobilizes any Shiga toxin-antibody complex present.Due to the gold labeling, a distinct red line is then formed.   
5.The remainder of the sampie continues to migrate to another binding reagent zone within the control zone, and also forms a further distinct red line (positive control).Regardless of whether any Shiga toxin is present or not, a distinct red line should always be formed in the control zone and confirms that the test is working correctly.

# CLINICAL TRIAL DATA

# Performance evaluation

ImmunoCard STAT! EHEC is a modification of Duopath Verotoxin GLISA (K031367), cleared to market to detect EHEC in stool samples that had been cultured on Sorbitol MacConkey plates. This premarket submission describes the evaluations performed with clinical samples to validate the product's new intended use with broth cultures inoculated with human stool.

This study was conc with sples test esh orlwgfrozenstorSaples wecolec United States, Canada and Argentina.A total of 360 stool sampies were evaluated in either GN, MacConkey Ma) broths or both.340 of these samples produced growth in GN broth, while 34 produced growth in Mac broTable identifes the ages of the patients from whom samples were colcte during the study.Tabe3 provides he gender of each patient.Table 4 summarizes the sensitivity and specificity obtained with Mac stool broth samples. Samples producing discrepant results between Premier EHEC and ImmunoCard

Table 3 Classification of patients from whom samples were collected based on gender.   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=3>Specimen Type</td></tr><tr><td rowspan=1 colspan=1>GN Samples</td><td rowspan=1 colspan=1>Male</td><td rowspan=1 colspan=1>Female</td><td rowspan=1 colspan=1>Not defined</td></tr><tr><td rowspan=1 colspan=1>Ciinicalsite3WS</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Total tested</td><td rowspan=1 colspan=1>37</td><td rowspan=1 colspan=1>51</td><td rowspan=1 colspan=1>213</td></tr><tr><td rowspan=1 colspan=1>Mean positive reaction strength</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>3.1</td><td rowspan=1 colspan=1>3.5</td></tr><tr><td rowspan=1 colspan=1>Positive reaction range</td><td rowspan=1 colspan=1>0.5-8.0</td><td rowspan=1 colspan=1>0.5-6.0</td><td rowspan=1 colspan=1>0.5-8.0</td></tr><tr><td rowspan=1 colspan=1>Clinical site42VENE4</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Total tested</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Mean positive reaction strength</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>Positive reaction range</td><td rowspan=1 colspan=1>0.5-5.0</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>Clinical site Totals</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Total tested</td><td rowspan=1 colspan=1>51</td><td rowspan=1 colspan=1>76</td><td rowspan=1 colspan=1>213</td></tr><tr><td rowspan=1 colspan=1>Mean positive reaction strength</td><td rowspan=1 colspan=1>1.9</td><td rowspan=1 colspan=1>3.1</td><td rowspan=1 colspan=1>3.5</td></tr><tr><td rowspan=1 colspan=1>Positive reaction range</td><td rowspan=1 colspan=1>0.5-5.0</td><td rowspan=1 colspan=1>0.5-6.0</td><td rowspan=1 colspan=1>0.5-8.0</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=3>Specimen Type</td></tr><tr><td rowspan=1 colspan=1>MAC Samples</td><td rowspan=1 colspan=1>Male</td><td rowspan=1 colspan=1>Female</td><td rowspan=1 colspan=1>Not defined</td></tr><tr><td rowspan=1 colspan=1>Clinicalsite3</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Total tested</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>213</td></tr><tr><td rowspan=1 colspan=1>Mean positive reaction strength</td><td rowspan=1 colspan=1>2.8</td><td rowspan=1 colspan=1>3.3</td><td rowspan=1 colspan=1>3.3</td></tr><tr><td rowspan=1 colspan=1>Positive reaction range</td><td rowspan=1 colspan=1>0.5-7.0</td><td rowspan=1 colspan=1>0.5-7.0</td><td rowspan=1 colspan=1>0.5-6.0</td></tr><tr><td rowspan=1 colspan=1>Clinical site 4*</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Total tested</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Mean positive reaction strength</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>Positive reaction range</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>Clinical site Totals</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Total tested</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>77</td><td rowspan=1 colspan=1>213</td></tr><tr><td rowspan=1 colspan=1>Mean positive reaction strength</td><td rowspan=1 colspan=1>2.9</td><td rowspan=1 colspan=1>3.3</td><td rowspan=1 colspan=1>3.3</td></tr><tr><td rowspan=1 colspan=1>Positive reaction range</td><td rowspan=1 colspan=1>0.5-7.0</td><td rowspan=1 colspan=1>0.5-7.0</td><td rowspan=1 colspan=1>0.5-6.0</td></tr></table>

STATEHEC were further analyzed using cytotoxin assay (Table These samples generally produced weak reactions (less than 0.300) in Premier HEC Table Someof the samples grew in MAC broth but not GN broth.

# Patient exclusion criteria

There are no patient exclusion criteria associated with ImmunoCard STAT! EHEC.

# Influence of other disease states

There is no influence by other disease states on test results

Table 2. Categories of patients by age from whom samples were collected for clinical studies   

<table><tr><td rowspan=1 colspan=1>Patient Age and Sample Storage GN Samples</td><td rowspan=1 colspan=1>birth to 1month</td><td rowspan=1 colspan=1>&gt;1 month to2 years</td><td rowspan=1 colspan=1>&gt;2 years to12 years</td><td rowspan=1 colspan=1>&gt;12 years to21 years</td><td rowspan=1 colspan=1>&gt;21 years</td><td rowspan=1 colspan=1>Not Defined</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>S</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Total tested</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>62</td><td rowspan=1 colspan=1>213</td></tr><tr><td rowspan=1 colspan=1>Mean positive reaction strength</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>3.6</td><td rowspan=1 colspan=1>2.6</td><td rowspan=1 colspan=1>2.4</td><td rowspan=1 colspan=1>3.5</td></tr><tr><td rowspan=1 colspan=1>Positive reaction range</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>1.0-5.0</td><td rowspan=1 colspan=1>0.5 - 6.0</td><td rowspan=1 colspan=1>0.5 - 6.0</td><td rowspan=1 colspan=1>0.5 - 8.0</td></tr><tr><td rowspan=1 colspan=1>Clinical site 4                        10</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>MA</td><td rowspan=1 colspan=1>RaNes</td><td rowspan=1 colspan=1>S</td><td rowspan=1 colspan=1>A</td></tr><tr><td rowspan=1 colspan=1>Total tested</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>35</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Mean positive reaction strength</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>Positive reaction range</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>Clinical site Totals6g</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>E</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>S</td><td rowspan=1 colspan=1>Me</td></tr><tr><td rowspan=1 colspan=1>Total tested</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>97</td><td rowspan=1 colspan=1>213</td></tr><tr><td rowspan=1 colspan=1>Mean positive reaction strength</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>3.6</td><td rowspan=1 colspan=1>2.6</td><td rowspan=1 colspan=1>2.3</td><td rowspan=1 colspan=1>All Negative</td></tr><tr><td rowspan=1 colspan=1>Positive reaction range</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>1.0-5.0</td><td rowspan=1 colspan=1>0.5 - 6.0</td><td rowspan=1 colspan=1>0.5 - 6.0</td><td rowspan=1 colspan=1>All Negative</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Patient Age and Sample Storage MAC Samples</td><td rowspan=1 colspan=1>birth to 1month</td><td rowspan=1 colspan=1>&gt;1 month to2 years</td><td rowspan=1 colspan=1>&gt;2 years to12 years</td><td rowspan=1 colspan=1>&gt;12 years to21 years</td><td rowspan=1 colspan=1>&gt;21 years</td><td rowspan=1 colspan=1>Not Defined</td></tr><tr><td rowspan=1 colspan=1>Clinical site 3       </td><td rowspan=1 colspan=1>   </td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Total tested</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>63</td><td rowspan=1 colspan=1>213</td></tr><tr><td rowspan=1 colspan=1>Mean positive reaction strength</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>3.9</td><td rowspan=1 colspan=1>2.6</td><td rowspan=1 colspan=1>3.1</td><td rowspan=1 colspan=1>3.3</td></tr><tr><td rowspan=1 colspan=1>Positive reaction range</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>0.5 - 6.0</td><td rowspan=1 colspan=1>0.5 -7.0</td><td rowspan=1 colspan=1>0.5-7.0</td><td rowspan=1 colspan=1>0.5 - 6.0</td></tr><tr><td rowspan=1 colspan=1>Clinical site 4</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>TOen</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Total tested</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>36</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Mean positive reaction strength</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>Positive reaction range</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>Clinical sito Totals9MOSETY</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>E</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>A</td></tr><tr><td rowspan=1 colspan=1>Total tested</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>99</td><td rowspan=1 colspan=1>213</td></tr><tr><td rowspan=1 colspan=1>Mean positive reaction strength</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>3.9</td><td rowspan=1 colspan=1>2.6</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>3.3</td></tr><tr><td rowspan=1 colspan=1>Positive reaction range</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>All Negative</td><td rowspan=1 colspan=1>0.5- 6.0</td><td rowspan=1 colspan=1>0.5 -7.0</td><td rowspan=1 colspan=1>0.5 ·7.0</td><td rowspan=1 colspan=1>0.5 - 6.0</td></tr></table>

Table 6. Anaiysis of samples producing discrepant results   
GN broth-enriched samples   

<table><tr><td rowspan=1 colspan=1>Site</td><td rowspan=1 colspan=1>SpecmeneEa</td><td rowspan=1 colspan=1>Specimen Storage</td><td rowspan=1 colspan=1>*</td><td rowspan=1 colspan=1>rettebsorbance</td><td rowspan=1 colspan=1>PremiertInterp</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>2831</td><td rowspan=1 colspan=1>Cary-Blair 2-8 C</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0.223</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>282</td><td rowspan=1 colspan=1>Unpreserved -70 C</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0.289</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Cytotoxin Positive</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>281</td><td rowspan=1 colspan=1>Unpreserved -70 C</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0.387</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>280</td><td rowspan=1 colspan=1>Unpreserved -70 C</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0.151</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>269</td><td rowspan=1 colspan=1>Unpreserved -70 C</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0.535</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Cytotoxin Positive</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>266</td><td rowspan=1 colspan=1>Unpreserved -70 C</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0.159</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>289</td><td rowspan=1 colspan=1>Unpreserved -70 C</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0.280</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Mac broth-enriched samples   

<table><tr><td rowspan=1 colspan=1>Site</td><td rowspan=1 colspan=1>SpecimerSerial #</td><td rowspan=1 colspan=1>Specimen Storage</td><td rowspan=1 colspan=1>eSResult</td><td rowspan=1 colspan=1>PremierAbsorbance</td><td rowspan=1 colspan=1>Premier Interp</td><td rowspan=1 colspan=1>CTA ResultCr</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>2831</td><td rowspan=1 colspan=1>Cary-Blair 2-8 C</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0.314</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Cytotoxin Positive</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>282</td><td rowspan=1 colspan=1>Unpreserved -70 C</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0.174</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>281</td><td rowspan=1 colspan=1>Unpreserved -70 C</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0.239</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Cytotoxin Positive</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>280</td><td rowspan=1 colspan=1>Unpreserved -70 C</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0.355</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Cytotoxin Positive</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>110</td><td rowspan=1 colspan=1>Unpreserved -70 C</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0.157</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Legend: CTA cytotoxin assay

<table><tr><td></td><td rowspan=1 colspan=2>Premier EHEC</td><td></td><td></td><td></td><td rowspan=1 colspan=1>Premier</td><td rowspan=1 colspan=1>EHEC</td><td></td><td></td><td></td><td></td><td></td><td rowspan=1 colspan=1>Premier</td><td rowspan=1 colspan=1>EHEC</td><td></td></tr><tr><td rowspan=1 colspan=1>ICS EHEC GN</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>ICS EHECMAC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=3></td><td rowspan=1 colspan=1>ICS EHECTotal</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=2 colspan=1>Positive</td><td rowspan=2 colspan=1>54</td><td rowspan=2 colspan=1>0</td><td rowspan=2 colspan=1>54</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>Positive</td><td rowspan=2 colspan=1>58</td><td rowspan=2 colspan=1>0</td><td rowspan=2 colspan=1>58</td><td rowspan=2 colspan=2></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=2 colspan=1>Positive</td><td rowspan=2 colspan=1>112</td><td rowspan=2 colspan=1>0</td></tr><tr><td rowspan=1 colspan=3></td><td></td></tr><tr><td rowspan=2 colspan=1>Negative</td><td rowspan=2 colspan=1>7</td><td rowspan=2 colspan=1>279</td><td rowspan=2 colspan=1>286</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>Negative</td><td rowspan=2 colspan=1>5</td><td rowspan=2 colspan=1>281</td><td rowspan=2 colspan=1>286</td><td rowspan=1 colspan=3></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=2 colspan=1>Negative</td><td rowspan=2 colspan=1>12</td></tr><tr><td rowspan=1 colspan=3></td><td></td><td></td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>61</td><td rowspan=1 colspan=1>279</td><td rowspan=1 colspan=1>340</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>63</td><td rowspan=1 colspan=1>281</td><td rowspan=1 colspan=1>344</td><td rowspan=1 colspan=3></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>124</td></tr><tr><td rowspan=2 colspan=1>Sensitivity</td><td rowspan=2 colspan=1>54/61</td><td rowspan=2 colspan=1>88.5%</td><td rowspan=2 colspan=1>77.8% - 95.3%</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>Sensitivity</td><td rowspan=2 colspan=1>58/63</td><td rowspan=2 colspan=1>92.1%</td><td rowspan=2 colspan=1>82.4% - 97.4%</td><td rowspan=2 colspan=2></td><td rowspan=1 colspan=1></td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>Sensitivity</td><td rowspan=2 colspan=1>112/124</td><td rowspan=2 colspan=1>90.3%</td></tr><tr><td rowspan=1 colspan=3></td></tr><tr><td rowspan=2 colspan=1>Specificity</td><td rowspan=2 colspan=1>279/279</td><td rowspan=2 colspan=1>100.0%</td><td rowspan=2 colspan=1>98.7% - 100%</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>Specificity</td><td rowspan=2 colspan=1>281/281</td><td rowspan=2 colspan=1>100.0%</td><td rowspan=2 colspan=1>98.7% - 100%</td><td rowspan=1 colspan=3></td><td rowspan=1 colspan=1></td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>Specificity</td><td rowspan=2 colspan=1>560/560</td></tr><tr><td></td><td rowspan=1 colspan=2></td><td></td></tr><tr><td rowspan=2 colspan=1>PPV</td><td rowspan=2 colspan=1>54/54</td><td rowspan=2 colspan=1>100.0%</td><td rowspan=2 colspan=1>93.4% - 100%</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>PPV</td><td rowspan=2 colspan=1>58/58</td><td rowspan=2 colspan=1>100.0%</td><td rowspan=2 colspan=1>93.8% - 100%</td><td rowspan=2 colspan=2></td><td rowspan=1 colspan=1></td><td rowspan=2 colspan=1>b</td><td rowspan=2 colspan=1>PPV</td><td rowspan=2 colspan=1>112/112</td><td rowspan=2 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=3></td></tr><tr><td rowspan=1 colspan=1>NPV</td><td rowspan=1 colspan=1>279/286</td><td rowspan=1 colspan=1>97.6%</td><td rowspan=1 colspan=1>95.0% - 99.0%</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>NPV</td><td rowspan=1 colspan=1>281/286</td><td rowspan=1 colspan=1>98.3%</td><td rowspan=1 colspan=1>96.0% - 99.4%</td><td rowspan=1 colspan=3></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>NPV</td><td rowspan=1 colspan=1>560/572</td></tr><tr><td rowspan=1 colspan=1>Correlation</td><td rowspan=1 colspan=1>333/340</td><td rowspan=1 colspan=1>97.9%</td><td rowspan=1 colspan=1>95.8% - 99.2%</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Correlation</td><td rowspan=1 colspan=1>339/344</td><td rowspan=1 colspan=1>98.5%</td><td rowspan=1 colspan=1>96.6% - 99.5%</td><td rowspan=1 colspan=3></td><td rowspan=1 colspan=1>Correlation</td><td rowspan=1 colspan=1>672/684</td><td rowspan=1 colspan=1>98.2%</td><td rowspan=1 colspan=1>97.0% - 99.1%</td></tr></table>

<table><tr><td></td><td rowspan=1 colspan=1>Premier</td><td rowspan=1 colspan=1>EHEC</td><td></td><td></td><td></td><td rowspan=1 colspan=1>Premier</td><td rowspan=1 colspan=1>EHEC</td><td></td><td></td><td></td><td></td><td></td><td rowspan=1 colspan=1>Premier</td><td rowspan=1 colspan=1>EHEC</td><td></td></tr><tr><td rowspan=1 colspan=1>ICS EHEC GN</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>ICS EHECMAC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=3></td><td rowspan=1 colspan=1>ICS EHECTotal</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=2 colspan=1>Positive</td><td rowspan=2 colspan=1>54</td><td rowspan=2 colspan=1>0</td><td rowspan=2 colspan=1>54</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>Positive</td><td rowspan=2 colspan=1>58</td><td rowspan=2 colspan=1>0</td><td rowspan=2 colspan=1>58</td><td rowspan=2 colspan=2></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=2 colspan=1>Positive</td><td rowspan=2 colspan=1>112</td><td rowspan=2 colspan=1>0</td></tr><tr><td rowspan=1 colspan=2></td><td></td></tr><tr><td rowspan=2 colspan=1>Negative</td><td rowspan=2 colspan=1>2</td><td rowspan=2 colspan=1>284</td><td rowspan=2 colspan=1>286</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>Negative</td><td rowspan=2 colspan=1>4</td><td rowspan=2 colspan=1>282</td><td rowspan=2 colspan=1>286</td><td rowspan=1 colspan=3></td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>Negative</td><td rowspan=2 colspan=1>6</td></tr><tr><td></td><td rowspan=1 colspan=2></td></tr><tr><td rowspan=2 colspan=1>Total</td><td rowspan=2 colspan=1>56</td><td rowspan=2 colspan=1>284</td><td rowspan=2 colspan=1>340</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>Total</td><td rowspan=2 colspan=1>62</td><td rowspan=2 colspan=1>282</td><td rowspan=2 colspan=1>344</td><td rowspan=1 colspan=3></td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>Total</td><td rowspan=2 colspan=1>118</td></tr><tr><td></td><td rowspan=1 colspan=2></td></tr><tr><td rowspan=2 colspan=1>Sensitivity</td><td rowspan=2 colspan=1>54/56</td><td rowspan=2 colspan=1>96.4%</td><td rowspan=2 colspan=1>87.7% - 99.6%</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>Sensitivity</td><td rowspan=2 colspan=1>58/62</td><td rowspan=2 colspan=1>93.5%</td><td rowspan=2 colspan=1>84.3% - 98.2%</td><td rowspan=2 colspan=2></td><td rowspan=1 colspan=1></td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>Sensitivity</td><td rowspan=2 colspan=1>112/118</td><td rowspan=2 colspan=1>94.9%</td></tr><tr><td rowspan=1 colspan=2></td></tr><tr><td rowspan=2 colspan=1>Specificity</td><td rowspan=2 colspan=1>284/284</td><td rowspan=2 colspan=1>100.0%</td><td rowspan=2 colspan=1>98.7% - 100%</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>Specificity</td><td rowspan=2 colspan=1>282/282</td><td rowspan=2 colspan=1>100.0%</td><td rowspan=2 colspan=1>98.7% - 100%</td><td rowspan=2 colspan=2></td><td rowspan=1 colspan=1></td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>Specificity</td><td rowspan=2 colspan=1>566/566</td><td rowspan=2 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=2></td></tr><tr><td rowspan=2 colspan=1>PPV</td><td rowspan=2 colspan=1>54/54</td><td rowspan=2 colspan=1>100.0%</td><td rowspan=2 colspan=1>93.4% - 100%</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>PPV</td><td rowspan=2 colspan=1>58/58</td><td rowspan=2 colspan=1>100.0%</td><td rowspan=2 colspan=1>93.8% - 100%</td><td rowspan=1 colspan=3></td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>PPV</td><td rowspan=2 colspan=1>112/112</td></tr><tr><td></td><td rowspan=1 colspan=2></td></tr><tr><td rowspan=2 colspan=1>NPV</td><td rowspan=2 colspan=1>284/286</td><td rowspan=2 colspan=1>99.3%</td><td rowspan=2 colspan=1>97.5% - 99.9%</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>NPV</td><td rowspan=2 colspan=1>282/286</td><td rowspan=2 colspan=1>98.6%</td><td rowspan=2 colspan=1>96.5% - 99.6%</td><td rowspan=2 colspan=2></td><td rowspan=1 colspan=1></td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>NPV</td><td rowspan=2 colspan=1>566/572</td><td rowspan=2 colspan=1>99.0%</td></tr><tr><td rowspan=1 colspan=3></td></tr><tr><td rowspan=1 colspan=1>Correlation</td><td rowspan=1 colspan=1>338/340</td><td rowspan=1 colspan=1>99.4%</td><td rowspan=1 colspan=1>97.9% - 99.9%</td><td rowspan=1 colspan=1>−</td><td rowspan=1 colspan=1>Correlation</td><td rowspan=1 colspan=1>340/344</td><td rowspan=1 colspan=1>98.8%</td><td rowspan=1 colspan=1>97.1% - 99.7%</td><td rowspan=1 colspan=3></td><td rowspan=1 colspan=1>Correlation</td><td rowspan=1 colspan=1>678/684</td><td rowspan=1 colspan=1>99.1%</td><td rowspan=1 colspan=1>98.1% - 99.7%</td></tr></table>

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>SampleQual.Result</td><td rowspan=1 colspan=6>Site 3</td><td rowspan=1 colspan=6>Site 4   xs2</td></tr><tr><td rowspan=1 colspan=1>Sample ID</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Day 1Run 1</td><td rowspan=1 colspan=1>Day 1Run 2</td><td rowspan=1 colspan=1>Day 2 Run 1</td><td rowspan=1 colspan=1>Day 2Run 2</td><td rowspan=1 colspan=1>Day 3Run 1</td><td rowspan=1 colspan=1>auy  2</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>P</td><td rowspan=1 colspan=1>R XCo0</td><td rowspan=1 colspan=1>RU</td><td rowspan=1 colspan=1>RaY 9 </td><td rowspan=1 colspan=1>Ru </td></tr><tr><td rowspan=1 colspan=1>1 HP ST1</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>7.0</td><td rowspan=1 colspan=1>7.0</td><td rowspan=1 colspan=1>7.0</td><td rowspan=1 colspan=1>7.0</td><td rowspan=1 colspan=1>7.0</td><td rowspan=1 colspan=1>7.0</td><td rowspan=1 colspan=1>7.0</td><td rowspan=1 colspan=1>70</td><td rowspan=1 colspan=1>8.0</td><td rowspan=1 colspan=1>7.0</td><td rowspan=1 colspan=1>70</td><td rowspan=1 colspan=1>60</td></tr><tr><td rowspan=1 colspan=1>2 HP ST2</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>7.0</td><td rowspan=1 colspan=1>7.0</td><td rowspan=1 colspan=1>7.0</td><td rowspan=1 colspan=1>7.0</td><td rowspan=1 colspan=1>7.0</td><td rowspan=1 colspan=1>7.0</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>8:0</td><td rowspan=1 colspan=1>70</td><td rowspan=1 colspan=1>6:0</td><td rowspan=1 colspan=1>8.0</td><td rowspan=1 colspan=1>70</td></tr><tr><td rowspan=1 colspan=1>3 Cut off LP ST1</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td></tr><tr><td rowspan=1 colspan=1>4 Cut off LP ST1</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>107</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>10</td></tr><tr><td rowspan=1 colspan=1>5 Cut off LP ST2</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>6 Cut off LP ST2</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>10</td></tr><tr><td rowspan=1 colspan=1>7 Cut off HN ST1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>00</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>8 Cut off HN ST1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>00</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>00</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>9 Cut off HN ST2</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>00</td><td rowspan=1 colspan=1>50.030</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>00</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>10 Cut off HN ST2</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>00</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>00</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>11LN</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>00</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>00</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>Average highnegative value</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>T</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1> </td></tr><tr><td rowspan=1 colspan=1>Average low positivevalue</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>2.6</td><td rowspan=1 colspan=1>2.6</td><td rowspan=1 colspan=1>2.4</td><td rowspan=1 colspan=1>2.6</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>13T</td><td rowspan=1 colspan=1>Sot</td><td rowspan=1 colspan=1> </td></tr><tr><td rowspan=1 colspan=1>Percent Correlation</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1> </td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%82</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=14>Correlation of cut off            Site 3                                               Site 4Specimens                100%                                               100%</td></tr><tr><td rowspan=1 colspan=14>Precision                  Site 3                                               Site 4100%                                               100%</td></tr></table>

# Comparison to predicate

The following table compares the outcomes of trials using ImmunoCard STAT! EHEC to the data published for the predicate device, Premier EHEC.

Table 8 Comparison of the clinical performance of ImmunoCard STAT! to Premier EHEC   

<table><tr><td rowspan=2 colspan=1>Performance Characteristics in Direct Comparison toClinical Status or Condition(Combined Samples)</td><td></td><td></td></tr><tr><td rowspan=1 colspan=1>ImmunoCard STAT!EHECCombined broths</td><td rowspan=1 colspan=1>Premier EHEC(predicate)Combined broths</td></tr><tr><td rowspan=1 colspan=1>Clinical Sensitivity</td><td rowspan=1 colspan=1>90.3%</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Clinical Specificity</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>97.9%</td></tr><tr><td rowspan=1 colspan=1>Predictive Value of a Positive Test</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>Not done</td></tr><tr><td rowspan=1 colspan=1>Predictive Value of a Negative Test</td><td rowspan=1 colspan=1>97.9%</td><td rowspan=1 colspan=1>Not done</td></tr><tr><td rowspan=1 colspan=1>Correlation</td><td rowspan=1 colspan=1>98.2%</td><td rowspan=1 colspan=1>98.1%</td></tr><tr><td rowspan=1 colspan=1>Performance characteristics</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Precision/Reproducibility</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Linearity/reportable range</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>Limit of detection</td><td rowspan=1 colspan=1>ST1 = 1.25 ng/mLST2 = 1.25 ng/mL</td><td rowspan=1 colspan=1>ST1 = 7 pg/wellST2 = 15 pg/well</td></tr><tr><td rowspan=1 colspan=1>Assay cutoff</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>OD 0.150 (dualwavelength</td></tr></table>

# CONCLUSIONS

ImmunoCard STAT!EHECcan beused to detect Shiga-toxin ormig strains f Ecoli in human stool samples. The perormance o hdevier he stool brohintenussubstantiay equivalent  the pree Premier EHEC

Ms. Susan Rolih Official Correspondent Meridian Bioscience, Inc. 3474 River Hills Drive Cincinnati, OH 45244

# FEB 1 4 2007

Re: k062546 Trade/Device Name: ImmunoCardSTAT! EHEC Regulation Number: 21 CFR 866.3255 Regulation Name: Escherichia coli serological reagents Regulatory Class: Class I Product Code: GMZ Dated: February 6, 2007 Received: February 6, 2007

Dear Ms. Rolih:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240)276-0450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free nurnber (800) 638-2041 or (301) 443-6597 or at its Internet address   
http://www.fda.gov/cdrh/dsma/dsmamain.html.

Sincerely yours, fall, ation

Sally A. Hojvat, M.Sc., Ph.D.   
Director   
Division of Microbiology Devices Office of In Vitro Diagnostic Device Evaluation and Safety   
Center for Devices and   
Radiological Health

# INDICATIONS FOR USE STATEMENT ImmunoCard STAT! EHEC

510(K) Number. K06254/

ImmunoCard STAT! EHEC is an immunochromatographic rapid test for the qualitative detection of Shiga toxins 1 and 2 (also called Verotoxins) produced by E. coli in cultures derived from cinical stool specimens. ImmunoCard STAT! EHEC is used in conjunction with the patient's clinical symptoms and other laboratory tests to aid in the diagnosis of diseases caused by enterohemorrhagic E. coli (EHEC) infections.

# Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

fuddiA ae

Office of In Vitro Diagnostic Device Evaluation and Safety

576 K062546